
Divyashakti reported an 82.98% decline in standalone net profit to Rs 0.08 crore for the quarter ended March 2026, with sales falling 52.33% to Rs 8.71 crore. For the full year, net profit dropped 58.66% to Rs 1.05 crore. In contrast, Divi's Laboratories saw a 13.44% rise in consolidated net profit to Rs 751 crore for the same quarter, with sales increasing 9.52% to Rs 2,831 crore. Its full-year net profit grew 17.21% to Rs 2,568 crore, supported by a 12.82% sales increase.
The articles focus on financial performance without political framing. Both companies' results are presented factually, with no political viewpoints or commentary. The coverage is strictly business-oriented, reflecting corporate earnings and market data without ideological perspectives.
The sentiment across the articles is mixed, reflecting contrasting financial outcomes. Divyashakti's significant profit and sales declines convey a negative tone, while Divi's Laboratories' growth in profit and sales imparts a positive tone. The overall coverage balances these opposing trends without emotional language.
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.
| Source | Their headline | Bias | Sentiment |
|---|---|---|---|
| economictimes | Divi's Laboratories Q4 Results: Cons PAT grows 13 YoY to Rs 751 crore, revenue up 10 ; Rs 30 per share dividend announced | Center | Positive |
| businessstandard | Divyashakti standalone net profit declines 82.98 in the March 2026 quarter | Center | Negative |
| businessstandard | Divi's Laboratories consolidated net profit rises 13.44 in the March 2026 quarter | Center | Positive |
businessstandard broke this story on 23 May, 07:50 am. Other outlets followed.
Story is receiving appropriate media attention relative to public interest.
Institutions and figures named across source coverage.
Select a news story to see related coverage from other media outlets.